Pfizer banks must swallow bitter fee pill

Bankers advising Pfizer are set to walk away empty-handed after the US pharmaceuticals giant’s ‘final’ £70bn offer for UK rival AstraZeneca was rejected on Monday. JP Morgan, Bank of America…